These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
168 related articles for article (PubMed ID: 29503844)
21. Cross-sectional study using primary care and cancer registration data to investigate patients with cancer presenting with non-specific symptoms. Pearson C; Poirier V; Fitzgerald K; Rubin G; Hamilton W BMJ Open; 2020 Jan; 10(1):e033008. PubMed ID: 31924638 [TBL] [Abstract][Full Text] [Related]
22. Time intervals and previous primary care consultations in the pathway to emergency cancer diagnosis. Bosch X; Montori-Palacin E; Calvo J; Carbonell I; Naval-Álvarez J; Moreno P; López-Soto A Cancer Epidemiol; 2023 Oct; 86():102445. PubMed ID: 37651939 [TBL] [Abstract][Full Text] [Related]
23. Description of the BRIGHTLIGHT cohort: the evaluation of teenage and young adult cancer services in England. Taylor RM; Fern LA; Barber J; Alvarez-Galvez J; Feltbower R; Morris S; Hooker L; McCabe MG; Gibson F; Raine R; Stark DP; Whelan JS BMJ Open; 2019 Apr; 9(4):e027797. PubMed ID: 31005941 [TBL] [Abstract][Full Text] [Related]
24. Are alarm symptoms predictive of cancer survival?: population-based cohort study. Dregan A; Møller H; Charlton J; Gulliford MC Br J Gen Pract; 2013 Dec; 63(617):e807-12. PubMed ID: 24351496 [TBL] [Abstract][Full Text] [Related]
25. Time intervals from first symptom to diagnosis for head and neck cancers: An analysis of linked patient reports and medical records from the UK. Allgar VL; Oliver SE; Chen H; Oviasu O; Johnson MJ; Macleod U Cancer Epidemiol; 2019 Apr; 59():37-45. PubMed ID: 30669114 [TBL] [Abstract][Full Text] [Related]
26. The relative length of the patient and the primary care interval in patients with 28 common and rarer cancers. Lyratzopoulos G; Saunders CL; Abel GA; McPhail S; Neal RD; Wardle J; Rubin GP Br J Cancer; 2015 Mar; 112 Suppl 1(Suppl 1):S35-40. PubMed ID: 25734380 [TBL] [Abstract][Full Text] [Related]
27. Survival of European adolescents and young adults diagnosed with cancer in 2000-07: population-based data from EUROCARE-5. Trama A; Botta L; Foschi R; Ferrari A; Stiller C; Desandes E; Maule MM; Merletti F; Gatta G; Lancet Oncol; 2016 Jul; 17(7):896-906. PubMed ID: 27237614 [TBL] [Abstract][Full Text] [Related]
28. Cancer suspicion in general practice, urgent referral and time to diagnosis: a population-based GP survey and registry study. Jensen H; Tørring ML; Olesen F; Overgaard J; Vedsted P BMC Cancer; 2014 Aug; 14():636. PubMed ID: 25175155 [TBL] [Abstract][Full Text] [Related]
29. Pre-referral GP consultations in patients subsequently diagnosed with rarer cancers: a study of patient-reported data. Mendonca SC; Abel GA; Lyratzopoulos G Br J Gen Pract; 2016 Mar; 66(644):e171-81. PubMed ID: 26917657 [TBL] [Abstract][Full Text] [Related]
30. Cancer in HIV-positive and HIV-negative adolescents and young adults in South Africa: a cross-sectional study. Dhokotera T; Bohlius J; Egger M; Spoerri A; Ncayiyana JR; Naidu G; Olago V; Zwahlen M; Singh E; Muchengeti M BMJ Open; 2021 Oct; 11(10):e043941. PubMed ID: 34663647 [TBL] [Abstract][Full Text] [Related]
31. Time to diagnosis among young patients with cancer. Winestone LE; Wilkes JJ; Puccetti D; Keegan THM; Henk HJ; McPheeters J; Kahn JM; Ginsberg J; Wong S; Timberline S; Malogolowkin M; Pollock BH; Alvarez E Pediatr Blood Cancer; 2024 Sep; 71(9):e30997. PubMed ID: 38864147 [TBL] [Abstract][Full Text] [Related]
32. Factors related with symptom duration until diagnosis and treatment of symptomatic colorectal cancer. Esteva M; Leiva A; Ramos M; Pita-Fernández S; González-Luján L; Casamitjana M; Sánchez MA; Pértega-Díaz S; Ruiz A; Gonzalez-Santamaría P; Martín-Rabadán M; Costa-Alcaraz AM; Espí A; Macià F; Segura JM; Lafita S; Arnal-Monreal F; Amengual I; Boscá-Watts MM; Hospital A; Manzano H; Magallón R; BMC Cancer; 2013 Feb; 13():87. PubMed ID: 23432789 [TBL] [Abstract][Full Text] [Related]
33. The frequency, nature and impact of GP-assessed avoidable delays in a population-based cohort of cancer patients. Swann R; Lyratzopoulos G; Rubin G; Pickworth E; McPhail S Cancer Epidemiol; 2020 Feb; 64():101617. PubMed ID: 31810885 [TBL] [Abstract][Full Text] [Related]
34. Risk of subsequent primary neoplasms in survivors of adolescent and young adult cancer (Teenage and Young Adult Cancer Survivor Study): a population-based, cohort study. Bright CJ; Reulen RC; Winter DL; Stark DP; McCabe MG; Edgar AB; Frobisher C; Hawkins MM Lancet Oncol; 2019 Apr; 20(4):531-545. PubMed ID: 30797674 [TBL] [Abstract][Full Text] [Related]
35. Measures of promptness of cancer diagnosis in primary care: secondary analysis of national audit data on patients with 18 common and rarer cancers. Lyratzopoulos G; Abel GA; McPhail S; Neal RD; Rubin GP Br J Cancer; 2013 Feb; 108(3):686-90. PubMed ID: 23392082 [TBL] [Abstract][Full Text] [Related]
36. Teledermatology for diagnosing skin cancer in adults. Chuchu N; Dinnes J; Takwoingi Y; Matin RN; Bayliss SE; Davenport C; Moreau JF; Bassett O; Godfrey K; O'Sullivan C; Walter FM; Motley R; Deeks JJ; Williams HC; Cochrane Database Syst Rev; 2018 Dec; 12(12):CD013193. PubMed ID: 30521686 [TBL] [Abstract][Full Text] [Related]
37. Cancer Profiles, Times to Treatment, and Survival for Adolescents and Young Adults: Comparisons with Children and Older Adults in New South Wales, Australia. Li M; Anazodo A; Dallapozza L; Baeza PK; Roder D; Currow D J Adolesc Young Adult Oncol; 2022 Oct; 11(5):443-450. PubMed ID: 34714131 [No Abstract] [Full Text] [Related]
38. Time intervals in the pathway to emergency cancer diagnosis. Bosch X; Montori-Palacin E; Naval-Álvarez J; Matas A; Moreno P; López-Soto A Future Oncol; 2023 Apr; 19(12):829-843. PubMed ID: 37170913 [No Abstract] [Full Text] [Related]
39. Evidence of increasing mortality with longer diagnostic intervals for five common cancers: a cohort study in primary care. Tørring ML; Frydenberg M; Hansen RP; Olesen F; Vedsted P Eur J Cancer; 2013 Jun; 49(9):2187-98. PubMed ID: 23453935 [TBL] [Abstract][Full Text] [Related]
40. Time intervals and routes to diagnosis for lung cancer in 10 jurisdictions: cross-sectional study findings from the International Cancer Benchmarking Partnership (ICBP). Menon U; Vedsted P; Zalounina Falborg A; Jensen H; Harrison S; Reguilon I; Barisic A; Bergin RJ; Brewster DH; Butler J; Brustugun OT; Bucher O; Cairnduff V; Gavin A; Grunfeld E; Harland E; Kalsi J; Knudsen AK; Lambe M; Law RJ; Lin Y; Malmberg M; Turner D; Neal RD; White V; Weller D BMJ Open; 2019 Nov; 9(11):e025895. PubMed ID: 31776134 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]